Skip to main content
Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
0.2510
-0.0338 (-11.87%)
At close: Nov 13, 2026, 4:00 PM EST
0.2718
+0.0208 (8.29%)
After-hours: Nov 13, 2026, 7:05 PM EST

Traws Pharma Revenue

In the year 2025, Traws Pharma had annual revenue of $2.79M with 1,134.51% growth. That makes Traws Pharma the 41,692nd largest company in the world by revenue and 5,617th in the United States.

Revenue (ttm)
$2.79M
Revenue Growth
+1,134.51%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
7
Market Cap
3.86M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.79M2.56M1,134.51%
Dec 31, 2024226.00K--
Dec 31, 2023226.00K--
Dec 31, 2022226.00K--
Dec 31, 2021226.00K-5.00K-2.16%
Dec 31, 2020231.00K-1.95M-89.42%
Dec 31, 20192.18M955.00K77.77%
Dec 31, 20181.23M441.00K56.04%
Dec 31, 2017787.00K-4.76M-85.81%
Dec 31, 20165.55M-5.91M-51.59%
Dec 31, 201511.46M10.66M1,332.00%
Dec 31, 2014800.00K-3.95M-83.17%
Dec 31, 20134.75M-41.44M-89.71%
Dec 31, 201246.19M44.70M3,006.25%
Dec 31, 20111.49M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Jupiter Neurosciences64.69K
Silo Pharma54.08K
Azitra7.50K
Creative Medical Technology Holdings3.00K
Ernexa Therapeutics1.00K
Revenue Rankings

TRAW News

More News